Resources

Type of publications
Regions
Diseases

5192 results found

2021 ∙ Collins-Fairclough, A. Donken, R. Nosyk, B. Dobson, S. Ogilivie, G. Sadarangani, M.

Non-inferior antibody levels for HPV16/18 after extended two-dose schedules compared with a six-month interval: findings of a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Renosa, M. D. C. Landicho, J. Wachinger, J. Dalglish, S. L. Barnighausen, K. Barnighausen, T. McMahon, S. A.

Nudging toward vaccination: a systematic review

  • All age groups
  • Pregnant women
  • Parents/caregivers
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Lee, Y. K. Huang, Y. H.

Ocular manifestations after receiving covid-19 vaccine: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Lu, Q. C. Zhang, T. Y. Bundhun, P. K. Chen, C.

One "misunderstood" health issue: demonstrating and communicating the safety of influenza a vaccination in pregnancy: a systematic review and meta-analysis

  • Pregnant women
  • Influenza
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Desta, M. Akalu, T. Y. Alamneh, Y. M. Talie, A. Alemu, A. A. Tessema, Z. Yibeltal, D. Alamneh, A. A. Ketema, D. B. Shiferaw, W. S. Getaneh, T.

Perinatal mortality and its association with antenatal care visit, maternal tetanus toxoid immunization and partograph utilization in Ethiopia: a meta-analysis

  • Africa
  • Ethiopia
  • Pregnant women
  • Tetanus
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Oyedeji, O. Maples, J. M. Gregory, S. Chamberlin, S. M. Gatwood, J. D. Wilson, A. Q. Zite, N. B. Kilgore, L. C.

Pharmacists’ perceived barriers to human papillomavirus (Hpv) vaccination: A systematic literature review

  • All age groups
  • Healthcare workers
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Marques Antunes, M. Duarte, G. S. Brito, D. Borges, M. Costa, J. Ferreira, J. J. Pinto, F. J. Caldeira, D.

Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis

  • Adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Zhu, X. Li, X.

Pneumococcal vaccine effect on hospitalisation rates of pneumonia in children: A meta-analysis

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Kheyrandish, S. Rastgar, A. Arab-Zozani, M. Sarab, G. A.

Portal Vein Thrombosis Might Develop by COVID-19 Infection or Vaccination: A Systematic Review of Case-Report Studies

  • Children
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Sabeena, S. Ravishankar, N.

Postvaccination prevalence of vaccine-Human Papillomavirus (vHPV) genotypes among the target population: A systematic review and meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...